{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:03:00Z","timestamp":1789599780132,"version":"build-2803163510"},"reference-count":101,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,6,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>During recent years, our understanding of the pathogenesis of inherited microcytic anemias has gained from the identification of several genes and proteins involved in systemic and cellular iron metabolism and heme syntheses. Numerous case reports illustrate that the implementation of these novel molecular discoveries in clinical practice has increased our understanding of the presentation, diagnosis, and management of these diseases. Integration of these insights into daily clinical practice will reduce delays in establishing a proper diagnosis, invasive and\/or costly diagnostic tests, and unnecessary or even detrimental treatments. To assist the clinician, we developed evidence-based multidisciplinary guidelines on the management of rare microcytic anemias due to genetic disorders of iron metabolism and heme synthesis. These genetic disorders may present at all ages, and therefore these guidelines are relevant for pediatricians as well as clinicians who treat adults. This article summarizes these clinical practice guidelines and includes background on pathogenesis, conclusions, and recommendations and a diagnostic flowchart to facilitate using these guidelines in the clinical setting.<\/jats:p>","DOI":"10.1182\/blood-2014-01-548776","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T01:40:02Z","timestamp":1395711602000},"page":"3873-3886","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":69,"title":["Practice guidelines for the diagnosis and management of microcytic anemias due to genetic disorders of iron metabolism or heme synthesis"],"prefix":"10.1182","volume":"123","author":[{"given":"Albertine E.","family":"Donker","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinier A. P.","family":"Raymakers","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Thom","family":"Vlasveld","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Bronovo Hospital, The Hague, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teus","family":"van Barneveld","sequence":"additional","affiliation":[{"name":"Netherlands Association of Medical Specialists, Utrecht, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieneke","family":"Terink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasja","family":"Dors","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Catharina Hospital, Eindhoven, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul P. T.","family":"Brons","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hemato-Oncology, Radboud University Medical Center, Nijmegen, The Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nine V. A. M.","family":"Knoers","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorine W.","family":"Swinkels","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2019111820421082900_B1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3324\/haematol.13619","article-title":"Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis.","volume":"94","author":"Iolascon","year":"2009","journal-title":"Haematologica"},{"key":"2019111820421082900_B2","first-page":"A1039","article-title":"New causes of microcytic anaemia: hereditary disorders of iron homeostasis [in Dutch].","volume":"154","author":"van Rooijen","year":"2010","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"1","key":"2019111820421082900_B3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2141.2008.07290.x","article-title":"Recent advances in the understanding of inherited sideroblastic anaemia.","volume":"143","author":"Camaschella","year":"2008","journal-title":"Br J Haematol"},{"key":"2019111820421082900_B4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1182\/asheducation-2011.1.525","article-title":"Congenital sideroblastic anemias: iron and heme lost in mitochondrial translation.","volume":"2011","author":"Fleming","year":"2011","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"4","key":"2019111820421082900_B5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/j.seminhematol.2009.07.001","article-title":"Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment.","volume":"46","author":"Camaschella","year":"2009","journal-title":"Semin Hematol"},{"issue":"6771","key":"2019111820421082900_B6","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/35001596","article-title":"Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter.","volume":"403","author":"Donovan","year":"2000","journal-title":"Nature"},{"issue":"21","key":"2019111820421082900_B7","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V122.21.4.4","article-title":"The erythroid factor erythroferrone and its role in iron homeostasis [abstract].","volume":"122","author":"Kautz","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2019111820421082900_B8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ajmg.c.30165","article-title":"Attitudes regarding predictive genetic testing in minors: a survey of European clinical geneticists.","volume":"148C","author":"Borry","year":"2008","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"1","key":"2019111820421082900_B9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10689-005-2581-5","article-title":"Guidelines for disclosing genetic information to family members: from development to use.","volume":"5","author":"Godard","year":"2006","journal-title":"Fam Cancer"},{"key":"2019111820421082900_B10","unstructured":"Mol BW, van Triest B, Arends AJ, et al. Kwaliteitskoepel medische dpecialisten. http:\/\/www.kwaliteitskoepel.nl\/assets\/structured-files\/2012\/Richtlijn+2_Opmaak+5.pdf. Accessed January 9, 2014."},{"issue":"18","key":"2019111820421082900_B11","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care.","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"issue":"7454","key":"2019111820421082900_B12","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations.","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"7650","key":"2019111820421082900_B13","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"2019111820421082900_B14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: regulation of Mammalian iron metabolism.","volume":"142","author":"Hentze","year":"2010","journal-title":"Cell"},{"key":"2019111820421082900_B15","author":"Grantham-McGregor"},{"issue":"4","key":"2019111820421082900_B16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMra1004967","article-title":"Iron overload in human disease.","volume":"366","author":"Fleming","year":"2012","journal-title":"N Engl J Med"},{"issue":"5879","key":"2019111820421082900_B17","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1126\/science.1157121","article-title":"The serine protease TMPRSS6 is required to sense iron deficiency.","volume":"320","author":"Du","year":"2008","journal-title":"Science"},{"issue":"22","key":"2019111820421082900_B18","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1182\/blood-2008-12-195594","article-title":"Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia.","volume":"113","author":"Silvestri","year":"2009","journal-title":"Blood"},{"issue":"5","key":"2019111820421082900_B19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ng.130","article-title":"Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA).","volume":"40","author":"Finberg","year":"2008","journal-title":"Nat Genet"},{"issue":"11","key":"2019111820421082900_B20","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/ng.456","article-title":"Common variants in TMPRSS6 are associated with iron status and erythrocyte volume.","volume":"41","author":"Benyamin","year":"2009","journal-title":"Nat Genet"},{"issue":"11","key":"2019111820421082900_B21","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/ng.462","article-title":"Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels.","volume":"41","author":"Chambers","year":"2009","journal-title":"Nat Genet"},{"issue":"10","key":"2019111820421082900_B22","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3324\/haematol.13342","article-title":"A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron.","volume":"93","author":"Melis","year":"2008","journal-title":"Haematologica"},{"key":"2019111820421082900_B23","author":"Hershko"},{"issue":"22","key":"2019111820421082900_B24","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V114.22.629.629","article-title":"The clinical and genetic spectrum of TMPRSS6 mutations leading to inappropriate hepcidin expression and iron refractory iron deficiency anemia (IRIDA) [abstract].","volume":"114","author":"Heeney","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2019111820421082900_B25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bcmd.2009.09.001","article-title":"Polymorphisms and mutations of human TMPRSS6 in iron deficiency anemia.","volume":"44","author":"Beutler","year":"2010","journal-title":"Blood Cells Mol Dis"},{"issue":"2","key":"2019111820421082900_B26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bcmd.2011.11.007","article-title":"Responsiveness to oral iron and ascorbic acid in a patient with IRIDA.","volume":"48","author":"Cau","year":"2012","journal-title":"Blood Cells Mol Dis"},{"issue":"6","key":"2019111820421082900_B27","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/ndt\/gft033","article-title":"Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement.","volume":"28","author":"Locatelli","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2019111820421082900_B28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00277-012-1618-8","article-title":"Administration of recombinant erythropoietin alone does not improve the phenotype in iron refractory iron deficiency anemia patients.","volume":"92","author":"Lehmberg","year":"2013","journal-title":"Ann Hematol"},{"issue":"19","key":"2019111820421082900_B29","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1093\/hmg\/ddp315","article-title":"Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms.","volume":"18","author":"Ramsay","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"12","key":"2019111820421082900_B30","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1373\/clinchem.2009.140053","article-title":"Hepcidin in human iron disorders: diagnostic implications.","volume":"57","author":"Kroot","year":"2011","journal-title":"Clin Chem"},{"issue":"1","key":"2019111820421082900_B31","doi-asserted-by":"crossref","first-page":"C75","DOI":"10.1152\/ajpcell.00621.2008","article-title":"Functional analysis and theoretical modeling of ferroportin reveals clustering of mutations according to phenotype.","volume":"298","author":"Wallace","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"issue":"7","key":"2019111820421082900_B32","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1091\/mbc.e07-01-0060","article-title":"The molecular mechanism of hepcidin-mediated ferroportin down-regulation.","volume":"18","author":"De Domenico","year":"2007","journal-title":"Mol Biol Cell"},{"issue":"1","key":"2019111820421082900_B33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bcmd.2003.08.003","article-title":"The ferroportin disease.","volume":"32","author":"Pietrangelo","year":"2004","journal-title":"Blood Cells Mol Dis"},{"issue":"2-3","key":"2019111820421082900_B34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000243798","article-title":"Rare types of genetic hemochromatosis.","volume":"122","author":"Camaschella","year":"2009","journal-title":"Acta Haematol"},{"issue":"5","key":"2019111820421082900_B35","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jhep.2010.05.016","article-title":"Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.","volume":"53","author":"Mayr","year":"2010","journal-title":"J Hepatol"},{"issue":"10","key":"2019111820421082900_B36","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1182\/blood-2005-02-0771","article-title":"Ferroportin mutations: a tale of two phenotypes.","volume":"105","author":"Nemeth","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2019111820421082900_B37","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jmb.2008.12.063","article-title":"Investigation of the biophysical and cell biological properties of ferroportin, a multipass integral membrane protein iron exporter.","volume":"386","author":"Rice","year":"2009","journal-title":"J Mol Biol"},{"key":"2019111820421082900_B38","first-page":"1","article-title":"Nutritional anemias. Report of a WHO Scientific Group.","volume":"405","author":"Blanc","year":"1968","journal-title":"WHO Tech Rep Ser"},{"issue":"19","key":"2019111820421082900_B39","doi-asserted-by":"crossref","first-page":"10812","DOI":"10.1073\/pnas.96.19.10812","article-title":"Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux.","volume":"96","author":"Harris","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2019111820421082900_B40","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/sj.emboj.7601735","article-title":"Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin.","volume":"26","author":"De Domenico","year":"2007","journal-title":"EMBO J"},{"issue":"3","key":"2019111820421082900_B41","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.53.3.617","article-title":"Estimation of the gene frequency of aceruloplasminemia in Japan.","volume":"53","author":"Miyajima","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"2019111820421082900_B42","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000148691","article-title":"The neurological presentation of ceruloplasmin gene mutations.","volume":"60","author":"McNeill","year":"2008","journal-title":"Eur Neurol"},{"issue":"6","key":"2019111820421082900_B43","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1182\/blood-2002-02-0584","article-title":"Anemia and iron overload due to compound heterozygosity for novel ceruloplasmin mutations.","volume":"100","author":"Bosio","year":"2002","journal-title":"Blood"},{"issue":"5","key":"2019111820421082900_B44","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5581\/1516-8484.20110104","article-title":"Aceruloplasminemia: a rare disease - diagnosis and treatment of two cases.","volume":"33","author":"Roberti","year":"2011","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"13","key":"2019111820421082900_B45","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.2169\/internalmedicine.52.0102","article-title":"Effectiveness of oral iron chelator treatment with deferasirox in an aceruloplasminemia patient with a novel ceruloplasmin gene mutation.","volume":"52","author":"Suzuki","year":"2013","journal-title":"Intern Med"},{"issue":"6","key":"2019111820421082900_B46","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jhep.2010.04.039","article-title":"Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.","volume":"53","author":"Finkenstedt","year":"2010","journal-title":"J Hepatol"},{"issue":"7","key":"2019111820421082900_B47","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.braindev.2007.01.001","article-title":"Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate.","volume":"29","author":"Kuhn","year":"2007","journal-title":"Brain Dev"},{"issue":"4","key":"2019111820421082900_B48","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jnnp.2007.120568","article-title":"Aceruloplasminaemia with progressive atrophy without brain iron overload: treatment with oral chelation.","volume":"79","author":"Skidmore","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"2019111820421082900_B49","first-page":"663","article-title":"Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus.","volume":"87","author":"Logan","year":"1994","journal-title":"QJM"},{"issue":"1","key":"2019111820421082900_B50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0022-510X(98)00015-X","article-title":"A novel splicing mutation in the ceruloplasmin gene responsible for hereditary ceruloplasmin deficiency with hemosiderosis.","volume":"156","author":"Yazaki","year":"1998","journal-title":"J Neurol Sci"},{"issue":"13","key":"2019111820421082900_B51","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1182\/blood.V96.13.4071","article-title":"Molecular characterization of a case of atransferrinemia.","volume":"96","author":"Beutler","year":"2000","journal-title":"Blood"},{"key":"2019111820421082900_B52","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1055\/s-0028-1113001","article-title":"Congenital atransferrinemia in a 7-year-old girl [in German].","volume":"86","author":"Heilmeyer","year":"1961","journal-title":"Dtsch Med Wochenschr"},{"issue":"1","key":"2019111820421082900_B53","first-page":"201","article-title":"Studies on familial hypotransferrinemia: unique clinical course and molecular pathology.","volume":"53","author":"Hayashi","year":"1993","journal-title":"Am J Hum Genet"},{"issue":"10","key":"2019111820421082900_B54","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3324\/haematol.11377","article-title":"Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia.","volume":"92","author":"Trombini","year":"2007","journal-title":"Haematologica"},{"issue":"2","key":"2019111820421082900_B55","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood-2010-05-287359","article-title":"Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice.","volume":"117","author":"Bartnikas","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2019111820421082900_B56","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/08880010902973251","article-title":"Severe hypochromic microcytic anemia in a patient with congenital atransferrinemia.","volume":"26","author":"Shamsian","year":"2009","journal-title":"Pediatr Hematol Oncol"},{"issue":"2","key":"2019111820421082900_B57","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ajcp\/96.2.215","article-title":"Congenital atransferrinemia. A case report and review of the literature.","volume":"96","author":"Hamill","year":"1991","journal-title":"Am J Clin Pathol"},{"issue":"18","key":"2019111820421082900_B58","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1055\/s-2008-1058745","article-title":"Congenital atransferrinemia [in German].","volume":"119","author":"Hromec","year":"1994","journal-title":"Dtsch Med Wochenschr"},{"issue":"6","key":"2019111820421082900_B59","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/sj.thj.6200063","article-title":"Biochemical and genetic defects underlying human congenital hypotransferrinemia.","volume":"1","author":"Goldwurm","year":"2000","journal-title":"Hematol J"},{"issue":"13","key":"2019111820421082900_B60","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1182\/blood.V98.13.3823","article-title":"Characterization of the iron transporter DMT1 (NRAMP2\/DCT1) in red blood cells of normal and anemic mk\/mk mice.","volume":"98","author":"Canonne-Hergaux","year":"2001","journal-title":"Blood"},{"issue":"4","key":"2019111820421082900_B61","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ng0897-383","article-title":"Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene.","volume":"16","author":"Fleming","year":"1997","journal-title":"Nat Genet"},{"issue":"5","key":"2019111820421082900_B62","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1182\/blood-2004-02-0731","article-title":"Molecular and cellular mechanisms underlying iron transport deficiency in microcytic anemia.","volume":"104","author":"Touret","year":"2004","journal-title":"Blood"},{"issue":"10","key":"2019111820421082900_B63","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1182\/blood-2004-01-0225","article-title":"Severe hypochromic microcytic anemia caused by a congenital defect of the iron transport pathway in erythroid cells.","volume":"103","author":"Priwitzerova","year":"2004","journal-title":"Blood"},{"issue":"1","key":"2019111820421082900_B64","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jpeds.2007.08.041","article-title":"Natural history of recessive inheritance of DMT1 mutations.","volume":"152","author":"Iolascon","year":"2008","journal-title":"J Pediatr"},{"issue":"1","key":"2019111820421082900_B65","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1182\/blood-2005-06-2477","article-title":"Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2).","volume":"107","author":"Iolascon","year":"2006","journal-title":"Blood"},{"issue":"11","key":"2019111820421082900_B66","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/ng1658","article-title":"Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells.","volume":"37","author":"Ohgami","year":"2005","journal-title":"Nat Genet"},{"issue":"10","key":"2019111820421082900_B67","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1182\/blood-2005-01-0379","article-title":"nm1054: a spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse.","volume":"106","author":"Ohgami","year":"2005","journal-title":"Blood"},{"issue":"25","key":"2019111820421082900_B68","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1182\/blood-2011-01-329011","article-title":"A novel type of congenital hypochromic anemia associated with a nonsense mutation in the STEAP3\/TSAP6 gene.","volume":"118","author":"Grandchamp","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2019111820421082900_B69","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ng.359","article-title":"Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia.","volume":"41","author":"Guernsey","year":"2009","journal-title":"Nat Genet"},{"issue":"6","key":"2019111820421082900_B70","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3324\/haematol.2010.039164","article-title":"Missense SLC25A38 variations play an important role in autosomal recessive inherited sideroblastic anemia.","volume":"96","author":"Kannengiesser","year":"2011","journal-title":"Haematologica"},{"issue":"8","key":"2019111820421082900_B71","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1182\/blood-2002-04-1212","article-title":"Involvement of ABC7 in the biosynthesis of heme in erythroid cells: interaction of ABC7 with ferrochelatase.","volume":"101","author":"Taketani","year":"2003","journal-title":"Blood"},{"issue":"5","key":"2019111820421082900_B72","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/hmg\/8.5.743","article-title":"Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA\/A).","volume":"8","author":"Allikmets","year":"1999","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2019111820421082900_B73","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ajh.2830410203","article-title":"5-Aminolevulinate synthase in sideroblastic anemias: mRNA and enzyme activity levels in bone marrow cells.","volume":"41","author":"Bottomley","year":"1992","journal-title":"Am J Hematol"},{"issue":"18","key":"2019111820421082900_B74","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1038\/sj.emboj.7600792","article-title":"Crystal structure of 5-aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans.","volume":"24","author":"Astner","year":"2005","journal-title":"EMBO J"},{"issue":"3","key":"2019111820421082900_B75","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ajh.23616","article-title":"X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA-binding site mutations.","volume":"89","author":"Campagna","year":"2014","journal-title":"Am J Hematol"},{"issue":"5","key":"2019111820421082900_B76","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1182\/blood.V93.5.1757.405a12_1757_1769","article-title":"Four new mutations in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causing X-linked sideroblastic anemia: increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coinheritance of hereditary hemochromatosis.","volume":"93","author":"Cotter","year":"1999","journal-title":"Blood"},{"key":"2019111820421082900_B77","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00000441-194505000-00001","article-title":"A severe type of hereditary anemia with elliptocytosis. Interesting sequence of splenectomy.","volume":"209","author":"Cooley","year":"1945","journal-title":"Am J Med Sci"},{"issue":"2","key":"2019111820421082900_B78","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/pbc.22244","article-title":"Systematic molecular genetic analysis of congenital sideroblastic anemia: evidence for genetic heterogeneity and identification of novel mutations.","volume":"54","author":"Bergmann","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2019111820421082900_B79","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/humu.21455","article-title":"Sideroblastic anemia: molecular analysis of the ALAS2 gene in a series of 29 probands and functional studies of 10 missense mutations.","volume":"32","author":"Ducamp","year":"2011","journal-title":"Hum Mutat"},{"issue":"1","key":"2019111820421082900_B80","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bcmd.2006.04.003","article-title":"X-linked sideroblastic anemia associated with a novel ALAS2 mutation and unfortunate skewed X-chromosome inactivation patterns.","volume":"37","author":"Aivado","year":"2006","journal-title":"Blood Cells Mol Dis"},{"issue":"13","key":"2019111820421082900_B81","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1182\/blood.V96.13.4363","article-title":"Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females.","volume":"96","author":"Cazzola","year":"2000","journal-title":"Blood"},{"issue":"4","key":"2019111820421082900_B82","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ajh.2830420415","article-title":"Pyridoxine responsive hereditary sideroblastic erythropoiesis and iron overload: two microcytic subpopulations in the affected male, one normocytic and one microcytic subpopulation in the obligate female carrier.","volume":"42","author":"Harris","year":"1993","journal-title":"Am J Hematol"},{"issue":"3","key":"2019111820421082900_B83","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.bcmd.2006.01.010","article-title":"Disparate phenotypic expression of ALAS2 R452H (nt 1407 G \u2014> A) in two brothers, one with severe sideroblastic anemia and iron overload, hepatic cirrhosis, and hepatocellular carcinoma.","volume":"36","author":"Barton","year":"2006","journal-title":"Blood Cells Mol Dis"},{"issue":"11","key":"2019111820421082900_B84","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1182\/blood-2002-09-2804","article-title":"Late-onset X-linked sideroblastic anemia following hemodialysis.","volume":"101","author":"Furuyama","year":"2003","journal-title":"Blood"},{"issue":"11","key":"2019111820421082900_B85","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1182\/blood.V84.11.3915.bloodjournal84113915","article-title":"X-linked sideroblastic anemia: identification of the mutation in the erythroid-specific delta-aminolevulinate synthase gene (ALAS2) in the original family described by Cooley.","volume":"84","author":"Cotter","year":"1994","journal-title":"Blood"},{"issue":"24","key":"2019111820421082900_B86","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMcibr1304338","article-title":"Treating iron overload.","volume":"368","author":"Camaschella","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"2019111820421082900_B87","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1172\/JCI40372","article-title":"Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblasts.","volume":"120","author":"Ye","year":"2010","journal-title":"J Clin Invest"},{"key":"2019111820421082900_B88","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/329394","article-title":"Erythropoiesis and iron sulfur cluster biogenesis.","volume":"2010","author":"Ye","year":"2010","journal-title":"Adv Hematol"},{"issue":"4","key":"2019111820421082900_B89","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood-2007-02-072520","article-title":"The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload.","volume":"110","author":"Camaschella","year":"2007","journal-title":"Blood"},{"key":"2019111820421082900_B90","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2119\/molmed.2012.00340","article-title":"Loss-of-function ferrochelatase and gain-of-function erythroid-specific 5-aminolevulinate synthase mutations causing erythropoietic protoporphyria and x-linked protoporphyria in North American patients reveal novel mutations and a high prevalence of X-linked protoporphyria.","volume":"19","author":"Balwani","year":"2013","journal-title":"Mol Med"},{"issue":"3","key":"2019111820421082900_B91","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2133.2010.09631.x","article-title":"Molecular epidemiology of erythropoietic protoporphyria in the U.K.","volume":"162","author":"Whatley","year":"2010","journal-title":"Br J Dermatol"},{"issue":"12","key":"2019111820421082900_B92","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1182\/blood-2007-04-088120","article-title":"Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria.","volume":"110","author":"Holme","year":"2007","journal-title":"Blood"},{"issue":"1","key":"2019111820421082900_B93","first-page":"45","article-title":"Excessive erythrocyte PPIX influences the hematologic status and iron metabolism in patients with dominant erythropoietic protoporphyria.","volume":"55","author":"Delaby","year":"2009","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"2019111820421082900_B94","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/asheducation.V2012.1.19.3795678","article-title":"The porphyrias: advances in diagnosis and treatment.","volume":"2012","author":"Balwani","year":"2012","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"4","key":"2019111820421082900_B95","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0190-9622(97)70249-4","article-title":"Congenital erythropoietic porphyria.","volume":"36","author":"Fritsch","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2019111820421082900_B96","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1172\/JCI10642","article-title":"Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria.","volume":"107","author":"Solis","year":"2001","journal-title":"J Clin Invest"},{"issue":"6","key":"2019111820421082900_B97","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood-2006-06-022848","article-title":"Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria.","volume":"109","author":"Phillips","year":"2007","journal-title":"Blood"},{"issue":"4","key":"2019111820421082900_B98","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2133.2012.11160.x","article-title":"Congenital erythropoietic porphyria: a single-observer clinical study of 29 cases.","volume":"167","author":"Katugampola","year":"2012","journal-title":"Br J Dermatol"},{"issue":"4","key":"2019111820421082900_B99","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/pde.12117","article-title":"Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation.","volume":"30","author":"Martinez Peinado","year":"2013","journal-title":"Pediatr Dermatol"},{"issue":"16","key":"2019111820421082900_B100","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM198604173141607","article-title":"Complete suppression of the symptoms of congenital erythropoietic porphyria by long-term treatment with high-level transfusions.","volume":"314","author":"Piomelli","year":"1986","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111820421082900_B101","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2141.2002.03557.x","article-title":"Congenital erythropoietic porphyria: advances in pathogenesis and treatment.","volume":"117","author":"Desnick","year":"2002","journal-title":"Br J Haematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/123\/25\/3873\/1464495\/3873.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/123\/25\/3873\/1464495\/3873.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T15:32:25Z","timestamp":1597591945000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/123\/25\/3873\/32884\/Practice-guidelines-for-the-diagnosis-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,19]]},"references-count":101,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2014,6,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2014-01-548776","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,19]]}}}